160 related articles for article (PubMed ID: 31538194)
1. VCAM-1 targeted alpha-particle therapy for early brain metastases.
Corroyer-Dulmont A; Valable S; Falzone N; Frelin-Labalme AM; Tietz O; Toutain J; Soto MS; Divoux D; Chazalviel L; Pérès EA; Sibson NR; Vallis KA; Bernaudin M
Neuro Oncol; 2020 Mar; 22(3):357-368. PubMed ID: 31538194
[TBL] [Abstract][Full Text] [Related]
2. Radionuclide spatial distribution and dose deposition for in vitro assessments of
Frelin-Labalme AM; Roger T; Falzone N; Quan Lee B; Sibson NR; Vallis KA; Bernaudin M; Valable S; Corroyer-Dulmont A
Med Phys; 2020 Mar; 47(3):1317-1326. PubMed ID: 31838744
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1.
Horak E; Hartmann F; Garmestani K; Wu C; Brechbiel M; Gansow OA; Landolfi NF; Waldmann TA
J Nucl Med; 1997 Dec; 38(12):1944-50. PubMed ID: 9430475
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice.
Corroyer-Dulmont A; Jaudet C; Frelin AM; Fantin J; Weyts K; Vallis KA; Falzone N; Sibson NR; Chérel M; Kraeber-Bodéré F; Batalla A; Bardet S; Bernaudin M; Valable S
Front Oncol; 2021; 11():714514. PubMed ID: 34504791
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. In situ Generated
Stenberg VY; Juzeniene A; Bruland ØS; Larsen RH
Curr Radiopharm; 2020; 13(2):130-141. PubMed ID: 32389119
[TBL] [Abstract][Full Text] [Related]
7. VCAM-1-targeted MRI Enables Detection of Brain Micrometastases from Different Primary Tumors.
Cheng VWT; Soto MS; Khrapitchev AA; Perez-Balderas F; Zakaria R; Jenkinson MD; Middleton MR; Sibson NR
Clin Cancer Res; 2019 Jan; 25(2):533-543. PubMed ID: 30389659
[TBL] [Abstract][Full Text] [Related]
8. Half brain irradiation in a murine model of breast cancer brain metastasis: magnetic resonance imaging and histological assessments of dose-response.
Zarghami N; Murrell DH; Jensen MD; Dick FA; Chambers AF; Foster PJ; Wong E
Radiat Oncol; 2018 Jun; 13(1):104. PubMed ID: 29859114
[TBL] [Abstract][Full Text] [Related]
9. Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin's lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003.
Maaland AF; Saidi A; Torgue J; Heyerdahl H; Stallons TAR; Kolstad A; Dahle J
PLoS One; 2020; 15(3):e0230526. PubMed ID: 32187209
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases.
Falzone N; Ackerman NL; Rosales LF; Bernal MA; Liu X; Peeters SG; Soto MS; Corroyer-Dulmont A; Bernaudin M; Grimoin E; Touzani O; Sibson NR; Vallis KA
Theranostics; 2018; 8(1):292-303. PubMed ID: 29290808
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice.
Kim LS; Huang S; Lu W; Lev DC; Price JE
Clin Exp Metastasis; 2004; 21(2):107-18. PubMed ID: 15168728
[TBL] [Abstract][Full Text] [Related]
12. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.
Langley RR; Carlisle R; Ma L; Specian RD; Gerritsen ME; Granger DN
Microcirculation; 2001 Oct; 8(5):335-45. PubMed ID: 11687945
[TBL] [Abstract][Full Text] [Related]
13. The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model.
Liu H; Kato Y; Erzinger SA; Kiriakova GM; Qian Y; Palmieri D; Steeg PS; Price JE
BMC Cancer; 2012 Dec; 12():583. PubMed ID: 23217186
[TBL] [Abstract][Full Text] [Related]
14. Significant systemic therapeutic effects of high-LET immunoradiation by 212Pb-trastuzumab against prostatic tumors of androgen-independent human prostate cancer in mice.
Tan Z; Chen P; Schneider N; Glover S; Cui L; Torgue J; Rixe O; Spitz HB; Dong Z
Int J Oncol; 2012 Jun; 40(6):1881-8. PubMed ID: 22322558
[TBL] [Abstract][Full Text] [Related]
15. Comparing the fate of brain metastatic breast cancer cells in different immune compromised mice with cellular magnetic resonance imaging.
Knier NN; Hamilton AM; Foster PJ
Clin Exp Metastasis; 2020 Aug; 37(4):465-475. PubMed ID: 32533389
[TBL] [Abstract][Full Text] [Related]
16.
Kasten BB; Oliver PG; Kim H; Fan J; Ferrone S; Zinn KR; Buchsbaum DJ
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561763
[TBL] [Abstract][Full Text] [Related]
17. Biological effect of lead-212 localized in the nucleus of mammalian cells: role of recoil energy in the radiotoxicity of internal alpha-particle emitters.
Azure MT; Archer RD; Sastry KS; Rao DV; Howell RW
Radiat Res; 1994 Nov; 140(2):276-83. PubMed ID: 7938477
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of human epidermal growth factor receptor 2 status and systemic therapy in breast cancer with brain metastases treated with radiotherapy.
Tsuruoka S; Kataoka M; Uwatsu K; Makita K; Tsuruoka K; Takata N; Ishikawa H; Hamamoto Y; Mochizuki T; Kido T
Asia Pac J Clin Oncol; 2023 Jun; 19(3):347-354. PubMed ID: 36281655
[TBL] [Abstract][Full Text] [Related]
19. The development of alpha-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma.
Rotmensch J; Atcher RW; Hines J; Grdina D; Schwartz JS; Toohill M; Herbst AL
Am J Obstet Gynecol; 1989 Apr; 160(4):789-97. PubMed ID: 2712112
[TBL] [Abstract][Full Text] [Related]
20. Antitumor Activity of Novel Bone-seeking, α-emitting
Juzeniene A; Bernoulli J; Suominen M; Halleen J; Larsen RH
Anticancer Res; 2018 Apr; 38(4):1947-1955. PubMed ID: 29599310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
